By Camille Mojica Rey, Contributing Writer
Follow Me On Twitter
In 2017, the largest global biotech and pharmaceutical companies employed an estimated 900,000 employees, according to Statista.com. Former employees of these Big Pharma companies are increasingly finding their skills marketable to small startups, either as consultants or, in many cases, in positions of leadership. These former Big Pharma employees are helping startups go further in the drug development process, whether their end goal is commercialization, an acquisition exit, or an IPO. And, in return, small companies are offering those with Big Pharma experience a chance to see what it’s like to have a large impact on the trajectory of a small company.